Details of the Drug Formulations

General Information of Drug (ID: DMG3Y89)

Drug Name
Trabectedin Drug Info
Synonyms Ecteinascidin; Ecteinascidin-743; Et-743; Yondelis (TN)
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Approved [1] , [2]
Ovarian cancer 2C73 Phase 3 [3]
Cross-matching ID
PubChem CID
108150
ChEBI ID
CHEBI:84050
CAS Number
114899-77-3
TTD ID
D03RTK
INTEDE ID
DR1625
ACDINA ID
D01496

Full List of Drug Formulations Containing This Drug

Trabectedin 1mg/vial powder
Company Formulation ID FDA Description
Janssen Prods F23313 Potassium Dihydrogen Phosphate; Sucrose; Phosphoric Acid; Potassium Hydroxide
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2774).
2 Natural products to drugs: natural product-derived compounds in clinical trials. Nat Prod Rep. 2008 Jun;25(3):475-516.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)